Kidney transplantation from donation after cardiac death donors: Lack of impact of delayed graft function on post-transplant outcomes

Clinical Transplantation

Volumn 25, Issue 2, 2011, Pages 255-264

  Singh, Rajinder P ^a   Farney, Alan C ^a   Rogers, Jeffrey ^a   Zuckerman, Jack ^a   Reeves Daniel, Amber ^a   Hartmann, Erica ^a   Iskandar, Samy ^a   Adams, Patricia ^a   Stratta, Robert J ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Delayed graft function; Donation after brain death; Donation after cardiac death; Expanded criteria donor; Kidney transplantation; Standard criteria donor; Warm ischemia

Indexed keywords

ACETYLSALICYLIC ACID; ALEMTUZUMAB; CEPHALOSPORIN; COTRIMOXAZOLE; CREATININE; DEXAMETHASONE; FLUCONAZOLE; LEFLUNOMIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NYSTATIN; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY; VALGANCICLOVIR;

ACUTE GRAFT REJECTION; ADULT; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BRAIN DEATH; CADAVER DONOR; COMPARATIVE STUDY; CREATININE BLOOD LEVEL; DELAYED GRAFT FUNCTION; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; FEMALE; FOLLOW UP; GRAFT FAILURE; GRAFT SURVIVAL; GROUPS BY AGE; HEART DEATH; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SINGLE DRUG DOSE; TREATMENT DURATION;

ADULT; BRAIN DEATH; CADAVER; DEATH, SUDDEN, CARDIAC; DELAYED GRAFT FUNCTION; FEMALE; GRAFT SURVIVAL; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SURVIVAL RATE; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; TREATMENT OUTCOME;

EID: 79953306237     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2010.01241.x     Document Type: Article

References (35)

1. Wolfe RA, Ashby VB, Milford EL et al. Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med 1999: 341: 1725.
2. Welters HH, Brockman JG, Deller R, SureLac B, Krieglstein CF, Senninger N. Kidney transplantation using donors with history of diabetes and hypertension. Transplant Proc 2006: 38: 664.
3. Sung RS, Guidinger MK, Christensen LL et al. Development and current status of ECD kidney transplantation. In: Cecka JM, Terasaki PI eds. Clinical Transplants 2005. Los Angeles: UCLA Immunogenetics Center, 2006: 37.
4. Locke JE, Segev DL, Warren DS, Dominici F, Simpkins CE, Montgomery RA. Outcomes of kidneys from donors after cardiac death: implications for allocation and preservation. Am J Transplant 2007: 7: 1797.
5. Chapman J, Bock A, Dussol B et al. Follow-up after renal transplantation with organs from donors after cardiac death. Transpl Int 2006: 19: 715.
6. Cooper JT, Chin LT, Krieger NR et al. Donation after cardiac death: the University of Wisconsin experience with renal transplantation. Am J Transplant 2004: 4: 1490.
7. Gok MA, Buckley PE, Shenton B et al. Long term graft function in kidneys from non-heart beating donors. A single-centre experience. Transplantation 2002: 74: 664.
8. Keizer-Karin M, De-Fijter Johan W, Haase-Kromwijk-Bernadette JJ-M et al. Non-heart-beating donor kidneys in the Netherlands: allocation and outcome of transplantation. Transplantation 2005: 79: 1195.
9. Rengel M, Kanter J, Puerta M, Anaya F, Rodriguez M, Verde E. Kidney transplantation with grafts from non-heart-beating donors. Transplant Proc 2006: 38: 890.
10. Perico N, Cattaneo D, Sayegh MH, Remuzzi G. Delayed graft function in kidney transplantation. Lancet 2004: 364: 1814.
11. Ojo AO, Wolfe RA, Held P, Port FK, Schmouder RL. Delayed graft function: risk factors and implications for renal allograft survival. Transplantation 1997: 63: 968.
12. Yarlagadda SG, Coca SG, Formica RN Jr, Poggio ED, Parikh E. Association between delayed graft function and allograft and patient survival: a systematic review and meta-analysis. Nephrol Dial Transplant 2009: 24: 1039.
13. Johnston O, O'Kelly P, Spencer S et al. Reduced graft function (with or without dialysis) vs immediate graft function - a comparison of long-term renal allograft survival. Nephrol Dial Transplant 2006: 21: 2270.
14. Pfaff WW, Howard RJ, Patton PR et al. Delayed graft function after renal transplantation. Transplantation 1998: 65: 219.
15. Boom H, Mallat MJ, De Fijter JW et al. Delayed graft function influences renal function, but not survival. Kidney Int 2000: 58: 859.
16. Gagandeep S, Matsuoka L, Mateo R et al. Expanding the donor kidney pool: utility of renal allografts procured in a setting of uncontrolled cardiac death. Am J Transplant 2006: 6: 1682.
17. Wijnen RMH, Booster MH, Stubenitsky BM, Boer J, Heineman E, Kootstra G. Outcome of transplantation of non-heart-beating donor kidneys. Lancet 1995: 345: 1067.
18. Nicholson ML, Horsburgh T, Doughman TM et al. Comparison of the results of renal transplants from conventional and non heart-beating cadaveric donors. Transplant Proc 1997: 29: 1386.
19. Farney A, Singh RP, Stratta RJ et al. Experience in renal and extrarenal transplantation with donation after cardiac death donors with selective use of extracorporeal support. J Am Coll Surg 2008: 206: 1028.
20. Kootstra G. Statement on non-heart beating donor programmes. Transplant Proc 1995: 27: 2965.
21. Stratta RJ, Moore PS, Farney AC et al. Influence of pulsatile perfusion preservation on outcomes in kidney transplantation from expanded criteria donors. J Am Coll Surg 2007: 204: 873.
22. Farney AC, Doares W, Rogers J et al. A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation. Transplantation 2009: 88: 810.
23. OPTN 2009, 2009.
24. Howard RJ. The challenging triangle: balancing outcomes, transplant numbers and costs. Am J Transplant 2007: 7: 2443.
25. Howard RJ, Schold JD, Cornell DL. A 10-year analysis of organ donation after cardiac death in the United States. Transplantation 2005: 80: 564.
26. McCullough KP, Keith DS, Meyer KH et al. Kidney and pancreas transplantation in the United States, 1998-2007. Am J Transplant 2009: 9(Part 2): 894.
27. Abt PL, Fisher CA, Singhal AK. Donation after cardiac death in the US: history and use. J Am Coll Surg 2006: 203: 208.
28. Kokkinos C, Antcliffe D, Nanidis T et al. Outcome of kidney transplantation from nonheart-beating versus heart-beating cadaveric donors. Transplantation 2007: 83: 1193.
29. Tojimbara T, Fuchinoue S, Iwadoh K et al. Improved outcomes of renal transplantation from cardiac death donors: a 30-year single center experience. Am J Transplant 2007: 7: 609.
30. Saidi RF, Elias N, Kawai T et al. Outcome of kidney transplantation using expanded criteria donors and donation after cardiac death kidneys: realities and costs. Am J Transplant 2007: 7: 2769.
31. Sudhindran S, Pettigrew GJ, Drain A et al. Outcome of transplantation using kidneys from controlled (Maastricht category 3) non-heart-beating donors. Clin Transplant 2003: 17: 93.
32. Gok MA, Asher JF, Shenton BK et al. Graft function after kidney transplantation from non-heartbeating donors according to Maastricht category. J Urol 2004: 172: 2331.
33. Asher J, Wilson C, Gok M et al. Factors predicting duration of delayed graft function in non-heart-beating donor kidney transplantation. Transplant Proc 2005: 37: 348.
34. Brook NR, White SA, Waller JR et al. Non-heart beating donor kidneys with delayed graft function have superior graft survival compared with conventional heart-beating donor kidneys that develop delayed graft function. Am J Transplant 2003: 3: 614.
35. Nicholson ML, Wheatley TJ, Horsburgh T, Edwards CM, Veitch PS, Bell PRF. The relative influence of delayed graft function and acute rejection on renal transplant survival. Transpl Int 1996: 9: 415.